ATE229183T1 - Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten - Google Patents

Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten

Info

Publication number
ATE229183T1
ATE229183T1 AT96930879T AT96930879T ATE229183T1 AT E229183 T1 ATE229183 T1 AT E229183T1 AT 96930879 T AT96930879 T AT 96930879T AT 96930879 T AT96930879 T AT 96930879T AT E229183 T1 ATE229183 T1 AT E229183T1
Authority
AT
Austria
Prior art keywords
levels
prostate cancer
apolipoprotein
measurement
body fluid
Prior art date
Application number
AT96930879T
Other languages
English (en)
Inventor
Wayne Tilley
Original Assignee
Signet Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signet Lab Inc filed Critical Signet Lab Inc
Application granted granted Critical
Publication of ATE229183T1 publication Critical patent/ATE229183T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/803—Stabe free radicals, e.g. spin immunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT96930879T 1995-09-15 1996-09-13 Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten ATE229183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US387495P 1995-09-15 1995-09-15
PCT/US1996/014753 WO1997010503A1 (en) 1995-09-15 1996-09-13 Method for screening for prostate cancer by measuring apolipoprotein d levels in body fluid

Publications (1)

Publication Number Publication Date
ATE229183T1 true ATE229183T1 (de) 2002-12-15

Family

ID=21708017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96930879T ATE229183T1 (de) 1995-09-15 1996-09-13 Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten

Country Status (8)

Country Link
US (1) US5804368A (de)
EP (1) EP0862739B1 (de)
JP (1) JP3564668B2 (de)
AT (1) ATE229183T1 (de)
AU (1) AU722666B2 (de)
CA (1) CA2232004C (de)
DE (1) DE69625236T2 (de)
WO (1) WO1997010503A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502227B1 (de) * 2005-08-08 2007-08-15 Vitateq Biotechnology Gmbh Verfahren zur diagnose von tumoren
EP3032258B1 (de) 2008-12-30 2021-05-12 Children's Medical Center Corporation Verfahren zur vorhersage akuter appendizitis

Also Published As

Publication number Publication date
US5804368A (en) 1998-09-08
AU722666B2 (en) 2000-08-10
DE69625236T2 (de) 2003-08-21
EP0862739A4 (de) 2001-06-06
CA2232004C (en) 2007-11-06
DE69625236D1 (de) 2003-01-16
EP0862739B1 (de) 2002-12-04
EP0862739A1 (de) 1998-09-09
CA2232004A1 (en) 1997-03-20
JP3564668B2 (ja) 2004-09-15
WO1997010503A1 (en) 1997-03-20
JPH11512525A (ja) 1999-10-26
AU6977996A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
HK1036834A1 (en) Differential diagnosis of neurodegeneration
ES8501531A1 (es) Un metodo y a unos reactivos para determinar ligandos en los fluidos biologicos
ES8502548A1 (es) Un metodo para determinar ligandos en una muestra.
DK0649535T3 (da) Fremgangsmåde til at forbedre målepræcisionen i optisk biosensor assays med detektering af rumligt dæmpede bølger
GR3018852T3 (en) Methods of detecting bone resorption in vivo
ATE298890T1 (de) Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker
ATE48157T1 (de) Ein zwitterion als bindungsmittel enthaltende zusammensetzung und testvorrichtung zum nachweis von leukozyten.
DE60128404D1 (de) Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
EP0218010A3 (de) Verfahren zur Bestimmung von Liganden und substituierte Carboxyfluoreszein-Markers zur Durchführung desselben
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
BR9300639A (pt) Particulas marcadoras para uso no ensaio de uma amostra de um fluido biologico,processo pra ensaiar uma amostra de fluido biologico,e,processo para ensaiar uma amostra de sangue
ATE229183T1 (de) Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DK1095271T3 (da) Fremgangsmåde til diagnose af hjertekar-sygdomme og tidlig aterosklerose
ATE377192T1 (de) Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls
ATA36892A (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens
ATE466284T1 (de) Bakterientestverfahren mit bindung einer intrazellularer enzyme
ATE13600T1 (de) Verfahren zur bestimmung der betalipoproteinfraktion (ldl) in koerperfluessigkeiten.
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
AU2836299A (en) Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins
ES8502261A1 (es) Un metodo para determinar ligandos en una muestra.
ATE119578T1 (de) Verfahren und reagenz zur bestimmung von antithrombin iii.
DE60027176D1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
DE69833546D1 (de) Verfahren zur bestimmung des procarboxypetidase-a- und carboxypeptidase-a-spiegels in biologischen flüssigkeiten
DE69922680D1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0862739

Country of ref document: EP

REN Ceased due to non-payment of the annual fee